- Home
- AKRO vs FIHL Comparison
AKRO vs FIHL Comparison
Compare AKRO & FIHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- FIHL
- Stock Information
- Founded
- AKRO 2017
- FIHL 2014
- Country
- AKRO United States
- FIHL Bermuda
- Employees
- AKRO N/A
- FIHL N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- FIHL
- Sector
- AKRO Health Care
- FIHL
- Exchange
- AKRO Nasdaq
- FIHL Nasdaq
- Market Cap
- AKRO 1.8B
- FIHL 1.8B
- IPO Year
- AKRO 2019
- FIHL 2023
- Fundamental
- Price
- AKRO $51.84
- FIHL $14.52
- Analyst Decision
- AKRO Strong Buy
- FIHL Buy
- Analyst Count
- AKRO 9
- FIHL 8
- Target Price
- AKRO $75.86
- FIHL $20.38
- AVG Volume (30 Days)
- AKRO 2.2M
- FIHL 490.9K
- Earning Date
- AKRO 03-03-2025
- FIHL 02-25-2025
- Dividend Yield
- AKRO N/A
- FIHL 2.76%
- EPS Growth
- AKRO N/A
- FIHL N/A
- EPS
- AKRO N/A
- FIHL 3.96
- Revenue
- AKRO N/A
- FIHL $2,299,900,000.00
- Revenue This Year
- AKRO N/A
- FIHL N/A
- Revenue Next Year
- AKRO N/A
- FIHL $13.72
- P/E Ratio
- AKRO N/A
- FIHL $3.66
- Revenue Growth
- AKRO N/A
- FIHL N/A
- 52 Week Low
- AKRO $17.86
- FIHL $13.87
- 52 Week High
- AKRO $58.40
- FIHL $21.32
- Technical
- Relative Strength Index (RSI)
- AKRO 65.39
- FIHL 23.20
- Support Level
- AKRO $48.70
- FIHL $16.10
- Resistance Level
- AKRO $51.40
- FIHL $16.55
- Average True Range (ATR)
- AKRO 2.29
- FIHL 0.47
- MACD
- AKRO -0.90
- FIHL -0.12
- Stochastic Oscillator
- AKRO 35.50
- FIHL 4.55
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.
About FIHL Fidelis Insurance Holdings Limited
Fidelis Insurance Holdings Ltd is a global (re)insurance company. It classify the business into three underwriting segments, namely Bespoke, Specialty and Reinsurance. Specialty primarily comprises property D&F, energy, marine and aviation lines. Bespoke primarily comprises credit and political risk and other tailored solutions for clients including transactional liabilities and credit insurance. Reinsurance primarily comprises property reinsurance.